559 results on '"Correa-Rotter, Ricardo"'
Search Results
2. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting
3. Mind the gap in kidney care: translating what we know into what we do
4. Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex
5. New and emerging therapies for diabetic kidney disease
6. Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism
7. Dietary inflammatory index and lower glomerular filtration rate in Mexican adults
8. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study
9. Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
10. Association between soft drinks intake and low glomerular filtration rate in Mexican adults: Results from RenMex
11. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria
12. Representation of Low- and Middle-Income Countries in CKD Drug Trials: A Systematic Review
13. Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis
14. Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
15. Validation of an equation for free calcium estimation: accuracy improves after adjustment for phosphate and CO2
16. Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
17. Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure
18. Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions
19. The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
20. Mind the Gap in Kidney Care: Translating What We Know Into What We Do.
21. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
22. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
23. Frequency of Intradialytic Hypotension Events Do Not Increase with Oral Nutritional Supplementation during Hemodialysis Treatment: A Randomized Controlled Trial
24. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
25. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
26. Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
27. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
28. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
29. 423.9: The First 52 Global Kidney Exchange Transplants: Overcoming Multiple Barriers to Transplantation
30. Correction of anemia by dapagliflozin in patients with type 2 diabetes
31. Prevalence of thyroid dysfunction in healthy adults according to the estimated iodine intake in 24-hour urine samples: The SALMEX cohort
32. Mesoamerican Nephropathy
33. Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial.
34. Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
35. ICU Admission During the COVID-19 Pandemic in Overwhelmed Institutions: Is CKD a Significant Risk Factor for Consideration in ICU Admission?: PUB039
36. Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease
37. Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: A comparative cohort study
38. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial
39. Mind the gap in kidney care: translating what we know into what we do
40. Transcultural adaptation and validation of the Mexican version of the kidney disease questionnaire KDQOL-SF36 version 1.3
41. In reply to: "Should we consider renaming 'Mesoamerican Nephropathy' as Nephropathy of Unknown Cause in Agricultural Labourers (NUCAL)?"
42. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
43. ADVANCES IN HEMODIALYSIS IN THE LAST DECADE IN LATIN AMERICA.
44. Effects of Dapagliflozin on Kidney Function, Cardiovascular Events, and All-Cause Mortality According to Cause of Kidney Disease in the DAPA-CKD Trial: FR-OR58
45. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
46. New 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline: Healthcare Impact in Mexico and Other Developing Countries
47. Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin
48. Optimizing peritoneal dialysis initiation: A comparative cohort study of catheter placement methods for shortening break‐in periods.
49. Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial.
50. Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.